However, P V Appaji, former director general of Pharmexcil finds that the interest of Indian companies to get approvals for ...

West Pharmaceutical reported Q4 earnings and revenue above expectations but issued a weak 2025 forecast. William Blair ...

Glenmark Pharmaceuticals Q3 Results 2025:Glenmark Pharmaceuticals declared their Q3 results on 14 Feb, 2025, revealing a ...

Ascendis Pharma beat Q4 earnings and revenue estimates, driven by a $100M Novo Nordisk deal and Yorvipath's EU launch.

The president has said the law is unfair to U.S. businesses. But lawyers say weakening it could end up costing corporate ...

The three-day-long 16th Asia Pharma Expo'-2025 kicked off at the Bangladesh-China Friendship Exhibition Center in Purbachal New Town today (12 February). The Bangladesh Association of Pharmaceutical ...

Revenue decreased by 37.41% YoY & profit decreased by 37.47% YoY, profit at ₹133 crore and revenue at ₹474.8 crore.

Q4 2024 Earnings Call Transcript February 13, 2025 Vanda Pharmaceuticals Inc. beats earnings expectations. Reported EPS is ...

PHOENIX, Ariz. (KVOA)— Attorney general Kris Mayes is suing a pharmaceutical company for allegedly endangering asthma ...

MALMO, SWEDEN / ACCESS Newswire / February 12, 2025 / Ascelia Pharma (STO:ACE) today announces that the Nomination Committee in preparation for the Annual General Meeting (AGM) on 7 May 2025 has been ...

Inmed Pharmaceuticals Inc. ( ($INM) ) has released its Q2 earnings. Here is a breakdown of the information Inmed ...

Kobayashi Pharmaceutical Co. on Feb. 10 posted its first full-year profit decline since going public in 1999 as the health ...